Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

FF vs BIOX vs BG vs CF

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FF
FutureFuel Corp.

Chemicals

Basic MaterialsNYSE • US
Market Cap$211M
5Y Perf.-63.3%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$30M
5Y Perf.-92.9%
BG
Bunge Global S.A.

Agricultural Farm Products

Consumer DefensiveNYSE • US
Market Cap$24.02B
5Y Perf.+217.3%
CF
CF Industries Holdings, Inc.

Agricultural Inputs

Basic MaterialsNYSE • US
Market Cap$18.24B
5Y Perf.+304.3%

FF vs BIOX vs BG vs CF — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FF logoFF
BIOX logoBIOX
BG logoBG
CF logoCF
IndustryChemicalsAgricultural InputsAgricultural Farm ProductsAgricultural Inputs
Market Cap$211M$30M$24.02B$18.24B
Revenue (TTM)$96M$318M$80.54B$7.41B
Net Income (TTM)$-49M$-53M$686M$1.76B
Gross Margin0.1%39.1%5.2%40.4%
Operating Margin-55.3%0.2%2.4%35.7%
Forward P/E14.4x8.4x
Total Debt$0.00$277M$16.95B$3.95B
Cash & Equiv.$51M$33M$1.14B$1.98B

FF vs BIOX vs BG vs CFLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FF
BIOX
BG
CF
StockMay 20May 26Return
FutureFuel Corp. (FF)10036.7-63.3%
Bioceres Crop Solut… (BIOX)1007.1-92.9%
Bunge Global S.A. (BG)100317.3+217.3%
CF Industries Holdi… (CF)100404.3+304.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: FF vs BIOX vs BG vs CF

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BG leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. CF Industries Holdings, Inc. is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
FF
FutureFuel Corp.
The Lower-Volatility Pick

FF plays a supporting role in this comparison — it may shine differently against other peers.

Best for: basic materials exposure
BIOX
Bioceres Crop Solutions Corp.
The Secondary Option

BIOX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: basic materials exposure
BG
Bunge Global S.A.
The Income Pick

BG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 5 yrs, beta 0.25, yield 2.2%
  • Rev growth 32.4%, EPS growth -38.4%, 3Y rev CAGR 1.5%
  • Lower volatility, beta 0.25, Low D/E 97.3%, current ratio 1.61x
  • Beta 0.25, yield 2.2%, current ratio 1.61x
Best for: income & stability and growth exposure
CF
CF Industries Holdings, Inc.
The Long-Run Compounder

CF is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 338.1% 10Y total return vs BG's 140.3%
  • Lower P/E (8.4x vs 14.4x)
  • 23.7% margin vs FF's -51.6%
  • 12.4% ROA vs FF's -23.5%, ROIC 18.7% vs -39.8%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthBG logoBG32.4% revenue growth vs FF's -60.7%
ValueCF logoCFLower P/E (8.4x vs 14.4x)
Quality / MarginsCF logoCF23.7% margin vs FF's -51.6%
Stability / SafetyBG logoBGBeta 0.25 vs BIOX's 1.94
DividendsBG logoBG2.2% yield, 5-year raise streak, vs CF's 1.7%, (1 stock pays no dividend)
Momentum (1Y)BG logoBG+66.8% vs BIOX's -88.5%
Efficiency (ROA)CF logoCF12.4% ROA vs FF's -23.5%, ROIC 18.7% vs -39.8%

FF vs BIOX vs BG vs CF — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FFFutureFuel Corp.
FY 2025
Chemicals
62.2%$60M
Biofuels
37.8%$36M
BIOXBioceres Crop Solutions Corp.

Segment breakdown not available.

BGBunge Global S.A.
FY 2025
Milling Products
99.8%$1.5B
Other Products
0.2%$3M
CFCF Industries Holdings, Inc.
FY 2025
Ammonia
33.3%$2.2B
UAN
33.0%$2.2B
Urea
27.2%$1.8B
AN
6.4%$421M

FF vs BIOX vs BG vs CF — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCFLAGGINGFF

Income & Cash Flow (Last 12 Months)

CF leads this category, winning 5 of 6 comparable metrics.

BG is the larger business by revenue, generating $80.5B annually — 841.2x FF's $96M. CF is the more profitable business, keeping 23.7% of every revenue dollar as net income compared to FF's -51.6%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…BG logoBGBunge Global S.A.CF logoCFCF Industries Hol…
RevenueTrailing 12 months$96M$318M$80.5B$7.4B
EBITDAEarnings before interest/tax-$43M$21M$2.8B$3.5B
Net IncomeAfter-tax profit-$49M-$53M$686M$1.8B
Free Cash FlowCash after capex-$46M$37M$112M$1.6B
Gross MarginGross profit ÷ Revenue+0.1%+39.1%+5.2%+40.4%
Operating MarginEBIT ÷ Revenue-55.3%+0.2%+2.4%+35.7%
Net MarginNet income ÷ Revenue-51.6%-16.6%+0.9%+23.7%
FCF MarginFCF ÷ Revenue-48.0%+11.5%+0.1%+21.9%
Rev. Growth (YoY)Latest quarter vs prior year-67.7%-16.4%+87.8%+19.4%
EPS Growth (YoY)Latest quarter vs prior year-5.2%-37.3%-76.4%+115.1%
CF leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BIOX leads this category, winning 3 of 6 comparable metrics.

At 13.2x trailing earnings, CF trades at a 47% valuation discount to BG's 25.2x P/E. On an enterprise value basis, CF's 6.2x EV/EBITDA is more attractive than BG's 22.6x.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…BG logoBGBunge Global S.A.CF logoCFCF Industries Hol…
Market CapShares × price$211M$30M$24.0B$18.2B
Enterprise ValueMkt cap + debt − cash$159M$274M$39.8B$20.2B
Trailing P/EPrice ÷ TTM EPS-4.25x-0.58x25.16x13.24x
Forward P/EPrice ÷ next-FY EPS est.14.38x8.41x
PEG RatioP/E ÷ EPS growth rate0.30x
EV / EBITDAEnterprise value multiple20.01x22.60x6.19x
Price / SalesMarket cap ÷ Revenue2.20x0.09x0.34x2.57x
Price / BookPrice ÷ Book value/share1.36x0.10x1.18x2.48x
Price / FCFMarket cap ÷ FCF0.85x10.12x
BIOX leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

CF leads this category, winning 7 of 9 comparable metrics.

CF delivers a 22.3% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-29 for FF. CF carries lower financial leverage with a 0.51x debt-to-equity ratio, signaling a more conservative balance sheet compared to BG's 0.97x. On the Piotroski fundamental quality scale (0–9), CF scores 8/9 vs BG's 2/9, reflecting strong financial health.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…BG logoBGBunge Global S.A.CF logoCFCF Industries Hol…
ROE (TTM)Return on equity-28.6%-16.7%+4.3%+22.3%
ROA (TTM)Return on assets-23.5%-6.7%+1.6%+12.4%
ROICReturn on invested capital-39.8%-0.5%+3.3%+18.7%
ROCEReturn on capital employed-51.6%-0.8%+4.5%+18.3%
Piotroski ScoreFundamental quality 0–93328
Debt / EquityFinancial leverage0.94x0.97x0.51x
Net DebtTotal debt minus cash-$51M$244M$15.8B$2.0B
Cash & Equiv.Liquid assets$51M$33M$1.1B$2.0B
Total DebtShort + long-term debt$0$277M$17.0B$3.9B
Interest CoverageEBIT ÷ Interest expense-130.01x-0.07x3.10x16.31x
CF leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CF leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CF five years ago would be worth $23,091 today (with dividends reinvested), compared to $317 for BIOX. Over the past 12 months, BG leads with a +66.8% total return vs BIOX's -88.5%. The 3-year compound annual growth rate (CAGR) favors CF at 22.6% vs BIOX's -64.0% — a key indicator of consistent wealth creation.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…BG logoBGBunge Global S.A.CF logoCFCF Industries Hol…
YTD ReturnYear-to-date+52.8%-65.0%+34.4%+48.8%
1-Year ReturnPast 12 months+26.3%-88.5%+66.8%+49.6%
3-Year ReturnCumulative with dividends+3.6%-95.3%+46.3%+84.1%
5-Year ReturnCumulative with dividends-16.9%-96.8%+49.4%+130.9%
10-Year ReturnCumulative with dividends+55.5%-95.1%+140.3%+338.1%
CAGR (3Y)Annualised 3-year return+1.2%-64.0%+13.5%+22.6%
CF leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — FF and CF each lead in 1 of 2 comparable metrics.

CF is the less volatile stock with a -0.62 beta — it tends to amplify market swings less than BIOX's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FF currently trades 93.8% from its 52-week high vs BIOX's 9.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…BG logoBGBunge Global S.A.CF logoCFCF Industries Hol…
Beta (5Y)Sensitivity to S&P 5000.49x1.94x0.25x-0.62x
52-Week HighHighest price in past year$5.12$5.18$133.93$141.96
52-Week LowLowest price in past year$3.09$0.35$71.60$75.42
% of 52W HighCurrent price vs 52-week peak+93.8%+9.1%+92.4%+83.6%
RSI (14)Momentum oscillator 0–10063.344.651.847.0
Avg Volume (50D)Average daily shares traded520K804K1.7M4.9M
Evenly matched — FF and CF each lead in 1 of 2 comparable metrics.

Analyst Outlook

BG leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: FF as "Buy", BG as "Buy", CF as "Buy". Consensus price targets imply 8.0% upside for BG (target: $134) vs -8.3% for CF (target: $109). For income investors, BG offers the higher dividend yield at 2.23% vs CF's 1.69%.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…BG logoBGBunge Global S.A.CF logoCFCF Industries Hol…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$133.67$108.89
# AnalystsCovering analysts42541
Dividend YieldAnnual dividend ÷ price+0.0%+2.2%+1.7%
Dividend StreakConsecutive years of raises050
Dividend / ShareAnnual DPS$0.00$2.76$2.01
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.1%+2.3%0.0%
BG leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CF leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BIOX leads in 1 (Valuation Metrics). 1 tied.

Best OverallCF Industries Holdings, Inc. (CF)Leads 3 of 6 categories
Loading custom metrics...

FF vs BIOX vs BG vs CF: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FF or BIOX or BG or CF a better buy right now?

For growth investors, Bunge Global S.

A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -60. 7% for FutureFuel Corp. (FF). CF Industries Holdings, Inc. (CF) offers the better valuation at 13. 2x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate FutureFuel Corp. (FF) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FF or BIOX or BG or CF?

On trailing P/E, CF Industries Holdings, Inc.

(CF) is the cheapest at 13. 2x versus Bunge Global S. A. at 25. 2x. On forward P/E, CF Industries Holdings, Inc. is actually cheaper at 8. 4x.

03

Which is the better long-term investment — FF or BIOX or BG or CF?

Over the past 5 years, CF Industries Holdings, Inc.

(CF) delivered a total return of +130. 9%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: CF returned +338. 1% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FF or BIOX or BG or CF?

By beta (market sensitivity over 5 years), CF Industries Holdings, Inc.

(CF) is the lower-risk stock at -0. 62β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately -411% more volatile than CF relative to the S&P 500. On balance sheet safety, CF Industries Holdings, Inc. (CF) carries a lower debt/equity ratio of 51% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FF or BIOX or BG or CF?

By revenue growth (latest reported year), Bunge Global S.

A. (BG) is pulling ahead at 32. 4% versus -60. 7% for FutureFuel Corp. (FF). On earnings-per-share growth, the picture is similar: CF Industries Holdings, Inc. grew EPS 33. 1% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FF or BIOX or BG or CF?

CF Industries Holdings, Inc.

(CF) is the more profitable company, earning 20. 5% net margin versus -51. 6% for FutureFuel Corp. — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CF leads at 33. 4% versus -55. 3% for FF. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FF or BIOX or BG or CF more undervalued right now?

On forward earnings alone, CF Industries Holdings, Inc.

(CF) trades at 8. 4x forward P/E versus 14. 4x for Bunge Global S. A. — 6. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BG: 8. 0% to $133. 67.

08

Which pays a better dividend — FF or BIOX or BG or CF?

In this comparison, BG (2.

2% yield), CF (1. 7% yield) pay a dividend. FF, BIOX do not pay a meaningful dividend and should not be held primarily for income.

09

Is FF or BIOX or BG or CF better for a retirement portfolio?

For long-horizon retirement investors, CF Industries Holdings, Inc.

(CF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 62), 1. 7% yield, +338. 1% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CF: +338. 1%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FF and BIOX and BG and CF?

These companies operate in different sectors (FF (Basic Materials) and BIOX (Basic Materials) and BG (Consumer Defensive) and CF (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FF is a small-cap quality compounder stock; BIOX is a small-cap quality compounder stock; BG is a mid-cap high-growth stock; CF is a mid-cap high-growth stock. BG, CF pay a dividend while FF, BIOX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

FF

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Stocks Like

BG

High-Growth Disruptor

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 43%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

CF

High-Growth Quality Leader

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 14%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform FF and BIOX and BG and CF on the metrics below

Revenue Growth>
%
(FF: -67.7% · BIOX: -16.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.